Literature DB >> 28479489

Autoimmune diseases and their relation with immunological, neurological and endocrinological axes.

Nicolás Coronel-Restrepo1, Iván Posso-Osorio2, Juan Naranjo-Escobar2, Gabriel J Tobón3.   

Abstract

The immune response is complex, multifactorial, individualized and often unpredictable. There are multiple interconnected systems that allow a balance between physiological autoreactive processes and pathological autoimmunity with consequent organ-specific or systemic autoimmune disease. Based on the concept of the autoimmunity mosaic, up to 50% of autoimmune disorders do not have a clear etiological factor. In order to achieve a clear understanding of the different systems that influence the development of autoimmune diseases, the clinical auto-immunologist needs a dynamic and comprehensive vision of all interconnected pathways that maintain a precise balance in the organism. This has been and will remain a challenge. Understanding the different pathophysiological processes of these diseases will be the basis for predicting different clinical spectra and has the potential to offer innovative therapeutic approaches. This paper offers a practical overview of the bidirectional communication between the immune and endocrine system and the influence this has on the development of autoimmune diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Auto-antibodies; Autoimmune diseases; Cytokines; Hormones; Immune-neuroendocrine; Neuropeptides; Neurotransmitters

Mesh:

Substances:

Year:  2017        PMID: 28479489     DOI: 10.1016/j.autrev.2017.05.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  8 in total

1.  Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.

Authors:  Joseph H Oved; Christina S Y Lee; James B Bussel
Journal:  J Pediatr       Date:  2017-12       Impact factor: 4.406

Review 2.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 3.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

4.  Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.

Authors:  Yu-Qing Bao; Jun-Ping Wang; Zi-Wei Dai; Yan-Mei Mao; Jun Wu; Heng-Sheng Guo; Yuan-Rui Xia; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2019-09-16       Impact factor: 2.980

Review 5.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

Review 6.  IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.

Authors:  Raghu Patil Junjappa; Prakash Patil; Kashi Raj Bhattarai; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

7.  Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation.

Authors:  Chenyang Zhang; Ben J E Raveney; Hirohiko Hohjoh; Chiharu Tomi; Shinji Oki; Takashi Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

Review 8.  Prospects of the Use of Cell Therapy to Induce Immune Tolerance.

Authors:  Zhenkun Wang; Xiaolong Liu; Fenglin Cao; Joseph A Bellanti; Jin Zhou; Song Guo Zheng
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.